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Summary Single cell tumour suspensions were prepared from biopsy and urine samples from 28 patients with
muscle invasive transitional cell carcinoma of the bladder. Nuclear extracts (nucleoids) containing intact
chromatin were isolated from these cells and the condensation of DNA supercoils measured by the light
scattered from individual nucleoids within a flow cytometer. Exposure of these nucleoids to 10pgmlP'
ethidium bromide produced 78.9% increase in light scatter compared to those treated with 501 gml-'. This
finding is consistent with the known effect of ethidium bromide on DNA supercoiling and confirms that the
light scatter signal is responding to changes at this level of DNA organisation. Cell samples were also exposed
to 12 Gy of gamma radiation and the effect on nucleoid light scatter recorded. Of the patients studied prior to
radiotherapy, those with persistent disease 3 months after treatment generated an increase in nucleoid light
scatter of + 9.35 ± 4.8% after 12 Gy irradiation, of these, 2/14 produced nucleoids that relaxed by more than
10% compared to controls. Those patients with no evidence of disease after radiotherapy gave an increase in
nucleoid light scatter after in vitro irradiation of + 19.3 ± 4.5% of which 10/14 (71%) relaxed by more than
10%. It is proposed that the increased relaxation within the supercoiled DNA from patients whose tumours
were undetectable 3 months after therapy, is related to the inherent radiosensitivity of these tumour cells. Such
a difference in nucleoid response within tumour cells from patients that responded to radiation may arise due
to a decreased affinity of DNA loops for the nuclear matrix. This structural change, at a site associated with
the initiation of DNA synthesis, may affect the ability of cells to continue successful cell division after
radiation damage.
The radiosensitivity of established human tumour cell lines
varies considerably in the low dose region of the survival
curve (Deacon et al., 1984; Fertil & Malaise, 1985). From a
study of published survival curves, a dose of 2 Gy to 18
separate melanoma cell lines produced a surviving fraction of
cells that ranged from 0.2 to 0.82 (Deacon et al., 1984). An
increase in surviving fraction from 0.4 to 0.5 after a 2 Gy
single dose, will produce an 800 fold greater number of
surviving cells after 30 such treatments. Although this cal-
culation ignores the effect of cell proliferation and repair,
such differences in intrinsic radiosensitivity may be of
sufficient magnitude to affect the local eradication of a
tumour by radiation (Weichselbaum et al., 1985).
The treatment of muscle invasive bladder cancer com-
monly involves radiotherapy, with cystectomy reserved for
those patients where local disease control has not been
achieved. The latter option is only possible for those patients
that are fit for surgery and with no evidence of distant
disease. Using this treatment rationale, 40% 5-year survival
rates have been reported (Jenkins et al., 1988). Unfortu-
nately, tumours may progress to an inoperable stage while
the response to radiotherapy is being assessed (Quilty et al.,
1986). While this problem could be avoided by performing
primary cystectomy in all cases, it would entail unnecessary
surgery in patients whose tumours could be adequately con-
trolled by radiotherapy alone. A method of predicting the
radiation response of each patient would allow the
identification ofthose patients who may not benefit from first
line radiotherapy in both this and other tumours where a
similar dilemma exists. For this reason, a substantial effort is
being made to design analytical techniques which may
predict tumour response (Mitchell, 1988).
The most direct measurement of cellular radiosensitivity is
the clonogenic response of tumour cells grown in vitro (Puck
& Markus, 1956). To make such a measurement from
primary biopsy material will require several months of pre-
liminary cell culture before sufficient cells of a uniform
phenotype are obtained. However this time may be reduced
to approximately one month if cells are used directly from
the biopsy digest (West et al., 1989). Nevertheless any delay
naturally limits the impact of such data on patient manage-
ment. It has been suggested that the analysis could be
shortened by monitoring the growth of tumour cell plaques,
rather than single clonogens (Brock et al., 1985). As yet, no
correlation has been shown between in vitro radioresistance
measured by this technique and local disease control (Brock
et al., 1990). In a search for a more rapid measure of
radioresistance the induction and repair of DNA double
strand breaks has been studied. There is convincing evidence
that ineffective repair of DNA double strand breaks is res-
ponsible for the extreme radiosensitivity of the rodent cell
line xrs-5 (Jeggo & Kemp, 1983). Using human cell lines,
both the number of such breaks induced and the kinetics of
their repair have been correlated with cell killing, making the
DNA double strand break a potentially critical lesion in the
killing of cells by radiation (Wlodek & Hittleman, 1987;
Kelland et al., 1988; Schwartz et al., 1988). We have pre-
viously suggested that the ability of irradiated cells to repair
DNA double strand breaks may be related to chromatin
organization (Schwartz & Vaughan 1989). Thus the ability of
human cells to successfully rejoin DNA double strand breaks
may be the summation of a number of genetic factors, inclu-
ding the performance of DNA repair enzymes, as modified
by the local chromatin environment.
In addressing this aspect of cellular radioresistance we
have described a technique whereby the effect of irradiation
on DNA supercoil organisation is measured using flow
cytometry (Milner et al., 1987). With this technique, cells
treated with a high concentration salt buffer release DNA
with its higher order supercoiled structure intact (Cook &
Brazell, 1975). Such residual nuclei, or nucleoids, when
stained with increasing doses of ethidium bromide expand
and contract in size as the ethidium bromide first relaxes then
condenses the supercoiling ofindividual DNA loops (Cook &
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Brazell, 1976a; Vogelstein et al., 1980). Loops that have been
damaged, for example by radiation, fail to respond to
ethidium bromide-induced condensation and the resulting
nucleoids are therefore larger (Cook & Brazell, 1976b). These
variations in size can be monitored by centrifugation, micro-
scopy or in our case by flow cytometry (Cook & Brazell,
1976b; Kapiszewska et al., 1989; Milner et al., 1987). Using
the latter technique the amount of laser light scattered from
individual nucleoids is measured.
Using nucleoid flow cytometry we have been able to
confirm previous work with the V79 rodent cell line, linking
alterations in radiosensitivity to changes in nuclear supercoil-
ing (Olive et al., 1986; Gordon et al., 1990). We now report a
clinical study in patients undergoing radical radiotherapy for
muscle-invasive transitional cell carcinoma of the bladder. A
tumour biopsy was taken from each patient, analysed by
nucleoid flow cytometry, and the data subsequently cor-
related with local tumour control, three months after the
completion of therapy.
Methods
Patients
Thirty eight patients with histologically proven muscle in-
vasive (T2 or T3) transitional cell carcinoma of the bladder
were recruited. Tumour samples were received either at the
time of endoscopic resection or from voided urine. Patients
were subsequently treated with a radical course of external
beam fractionated radiotherapy, of approximately 52.5 Gy in
20 fractions. Three months after completion of radiotherapy
they underwent cystoscopic examination to determine the
presence or absence of persistent disease.
Sample collection andpreparation
Transurethral samples of tumour were transported fresh in
saline to the laboratory. Each sample was sliced into approx-
imately 2 mm cubes with crossed scalpel blades and incu-
bated in 4ml collagenase (2,000U per ml in Hams FlO
nutrient medium; Sigma, UK) at 37°C for 1 h. The specimen
was then passed through 38 ym mesh muslin gauze, washed
twice in medium and resuspended in Hams FIO supple-
mented with 10% bovine foetal calf serum to give a single
cell suspension. Samples oftumour cells received from voided
urine were centrifuged (800 x g for 5 min), washed twice in
the above media and resuspended to give a single cell suspen-
sion. Samples of the cell suspension were mounted on micro-
scope slides and separately stained with both Giemsa and
haematoxylin/eosin. The proportion of tumour cells present
was allocated by inspection as a percentage of the total
nucleated population.
Nucleoid analysis
A Becton Dickinson FACS 440 jet-in-air flow cytometer was
used as described previously (Milner et al., 1987). All samples
were run at standard settings of sheath fluid pressure (15 psi),
photomultiplier gain and voltage after preliminary optical
alignment using 11 and 151tm polystyrene beads. The stan-
dard operating conditions were chosen to place the forward
scatter data of both control and irradiated nucleoids within
the 256 channel dynamic range of the machine detectors. To
generate nucleoid scatter data, the position of the forward
obscurator bar was found to be critical. This bar is situated
in front of the forward light scatter detector and is used to
block the undeflected laser beam. To collect low angle light
scatter this bar is adjusted to present the minimum area to
the incident laser beam, consistent with blocking direct light
access to the forward scatter detector.
The cells to be used were divided into 1 ml aliquots at
approximately 1 x 106 cells per ml and placed on ice. Sam-
ples were then irradiated with 12-18 Gy from a cobalt-60
gamma source and replaced on ice. Immediately prior to
analysis, and within 45 min of irradiation, 100gsl (1 x I05) of
cells were mixed with 1 ml of lysis buffer containing 2M NaCl, 10mM Na2EDTA, 10mM Tris buffer and 0.1% Triton
X-100. Quadruplicate samples of irradiated and control cells
were stained with either 10 or 50jgml-'I ethidium bromide
(EB) immediately before analysis. Data from 10,000 cells
were accumulated triggering data acquisition on red (DNA)
fluorescence. Forward scatter, side scatter and red fluore-
scence histograms were recorded.
Cell culture
In an attempt to ascertain the reproducibility of the nucleoid
assay, two squamous cell carcinoma lines, SCC-25 and SQ- 20B were each analysed using the protocol outlined above.
These lines were derived from patients with tumours of the
head and neck who had failed conventional radiotherapy
treatment and the lines now exhibit a substantial difference in
radiosensitivity (Weichselbaum et al., 1986). Each cell line
was routinely grown as a sub-confluent monolayer in the
following media:- 70% Dulbecco's modification of Eagle's
medium and 20% Ham's F12, supplemented with 10% FCS,
50 U ml-' penicillin, 50 lAgml-' streptomycin (Both Sigma St
Louis, MO) and 0.5 fig ml-' hydrocortisone (Calbiochem:
San Diego, CA). For each experiment, a flask of the cell line
was trypsinised for approximately 10min in 0.25% trypsin and 0.03% EDTA in Hanks balanced salt solution (Sigma: St
Louis, MO). Prior to use each sample was washed once in
complete medium.
Results
Each single-cell preparation was examined for the presence of
tumour as determined by histological appearance. In addition
to tumour cells most preparations also contained red blood cells and polymorphonuclear neutrophils. Those samples where no tumour cells were positively identified by standard pathological criteria were excluded from the subsequent ana- lysis of tumour persistence (8/38). In addition, two patients who did not complete a radical course of radiotherapy were also excluded leaving 28 patients suitable for analysis. For
ten of the patients studied data were obtained from biopsy material, the remainder from urine samples. The mean age
was 70.8 years (Range 41-85 years), 25/28 were male. Four-
teen of the 28 patients examined three months after therapy
were found to have persistent disease.
The forward light scatter response of control and irrad- iated samples was quantified as the mean of 10,000 recorded
events. Comparing control and irradiated samples, the aver-
age change in forward light scatter after 12 Gy irradiation
was + 14.3 ± 3.35% (range - 5% to + 68%) of the control values. The average standard deviation for quadruplicate control and irradiated samples was 7.1% and 6.3% respec- tively. Eight samples also received 18 Gy irradiation and this increased their light scatter response at 12 Gy from + 15.5%-
± 2.0% to + 20.2% ± 2.4% compared to controls. This enhanced light scatter at 18 Gy suggests, at least for the eight samples studied, that the radiation dose-response curve had
not reached a plateau at 12Gy. A similar result was pre- viously found for the V79 line where nucleoid expansion continues at least until 15 Gy (Gordon et al., 1990). Forward
scatter histograms of nucleoids from control and irradiated cells for one patient are shown in Figure 1. Nineteen of the samples were separately exposed to 10ltgml-' of EB. All samples tested showed an enhanced light scatter with an
average increase of 78.9% (range: 2.2-250.5%). The light scatter histograms from one patient after treatment with both 10 and 5OIgml-' ethidium bromide are shown in Figure 2. The enhanced expansion of unirradiated nucleoids after ex-
posure to 10jig ml ' of ethidium bromide is produced by an unwinding torque generated by the intercalation of the ethidium bromide within the DNA. This response is charac- teristic of supercoiled DNA, confirming the integrity and
nature of the DNA within the nucleoids.DNA SUPERCOILNG AND RADIOSENSITIVITY 869
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Figure 1 The effect of 12 Gy irradiation on cells from one
patient followed by nucleoid analysis. (Control-left trace, 12 Gy-
right trace).
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persistent disease, 3 months after completion of radiotherapy.
The mean increase in light scatter, + 1 standard error,
for the group of patients with persistent disease was + 9.35-
± 4.8%, for the patients with no detectable tumour, + 19.3-
± 4.5%. The data for all patients are expressed graphically in
Figure 3. Two of the fourteen (14%) patients with persistent
tumour and ten of the fourteen (71%) who were free of
tumour at three months had an increase in forward light
scatter of more than 10% when compared to unirradiated
samples. Thus a greater than 10% increase in nucleoid light
scatter after in vitro irradiation is associated with tumour
control.
As decribed above, the samples collected contained a
variable amount of nucleated cells of non-tumour origin. To
determine the effect of the contaminating normal material,
the nucleoid scatter seen was compared with samples con-
taining either less than or greater than 50% tumour (Figure
4). There is a wide range in nucleoid scatter from each group,
however those samples with most tumour show the same
trend as the complete data set, that is tumour material taken
from those patients who have persistent disease after radio-
therapy are associated with a smaller radiation-induced in-
crease in light scatter, though this difference is not statis-
tically significant. It is apparent that the presence of such
normal cells within the study must be a confounding factor
in the interpretation of the results.
Discussion
To assess the biological response to radiotherapy, patients
underwent cystoscopic examination three months after com-
pletion of treatment. At this time the lethal effects on the
tumour should predominate over clonogenic repopulation
from any surviving tumour cells. Other workers have shown
that resistance to radiation treatment is seen in about half of
all patients with T2/T3 bladder cancer treated with 55 Gy of
fractionated radiotherapy, in agreement with our data (Jen-
kins et al., 1990). In the study cited above, the presence of
squamous cell metaplasia and/or beta human chorionic gon-
adotrophin, but not the degree of aneuploidy, was associated
with radiotherapy failure. We are continuing our study to
address the long term response to treatment but in this report
we are primarily concerned with the intrinsic radiosensitivity
of the irradiated tumour.
All samples were analysed on the flow cytometer to deter-
mine the change in light scatter from individual nucleoids
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Figure 2 Exposure of nucleoids from one patient to either
10lag ml ethidium bromine (right trace) where most of the super-
coiled DNA loops are unwound, or 50jigml-' ethidium bromide
(left trace) after loop recompaction has occurred.
Experiments with the two cell lines were carried out four
times over a period of 3 months. The relatively radiosensitive
cell line SCC-25 (Surviving fraction at 2 Gy, SF2 = 0.35)
scattered 43% (SE = ± 3.7%) more light than controls at
the single dose of 12 Gy. For the resistant line SQ-20B
(SF2 = 0.51) an 11.9% (SE = ± 2.3%) increase was found
after 12 Gy. This relationship between radiosensitivity and
light scatter is in accord with our previous findings with V79
cells and supports the view that, within these lines, the
expression of radiosensitivity can be estimated from the
nucleoid scatter response data. These data will be presented in
full elsewhere. The absolute amount of light scatter detected
for each of these lines covers the low and high range of data
generated from the patient samples and this is therefore a
relevant guide to the intrinsic variability of the technique.
To analyse the patient response, the data were divided into
those patients that were free of tumour and those that had
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Figure 3 Comparison of the nucleoid response after radiation
subdivided into those patients that were free of tumour, three
months after therapy (close circles) with those expressing persis-
tent disease (open circles). Negative and zero changes in scatter
are included on this logrithmic plot for completeness (small sym-
bols). All the data from each group was analysed by the Mann
Whitney non-parametric statistic and the distributions were
found to be significantly different at the P = 0.05 level.
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Figure 4 Percentage increase in nucleoid light scatter( s.e.)
produced by 12 Gy irradiation of intact cells, correlated to
tumour content. Those patients who had persistent disease 6
months after treatment (open bars) and the highest tumour con-
tent showed the same trend as the complete data set in having a
smaller increase in radiation-induced nucleoid scatter than those
patients whose disease was controlled (closed bars), however the
differences were not statistically significant.
after 12 Gy irradiation. The amount of light scattered is
approximately proportional to the nucleoid size and after
irradiation varied from a 5% decrease to 68% increase when
compared to the controls (Figure 1). Inhibition of ethidium
bromide rewinding of nucleoid supercoils is thought to be
due to the presence of single strand breaks in DNA. A break
in one strand of a double stranded DNA loop does not
permit the generation of a coiling torque after ethidium
bromide intercalation (Cook et al., 1976b). To confirm the
nature of the DNA organisation detected by this assay, 19 of
the 28 samples were also exposed to lO1Lgml-' of ethidium
bromide, such that individual DNA supercoils were unwound
(Figure 2). All of these samples expressed a larger mean
forward scatter at the lower dose, consistent with a relaxa-
tion of the supercoiling within individual loops of DNA
induced by the lower concentration of ethidium bromide
(Vogelstein et al., 1980).
Comparing the effect of in vitro tumour irradiation on
nucleoid light scatter, cells from those patients with persistent
disease are associated with a smaller increase in nucleoid
light scatter after sample irradiation than those whose
tumour was undetectable three months after treatment
(P = 0.05; Figure 3). Based on these data, patients whose
tumour cells exhibit a small increase in nucleoid light scatter
after irradiation appear more likely to fail radiotherapy. This
correlation is complicated by the presence of normal cell
contamination in some samples, though as shown in Figure
4, those samples with the highest tumour content exhibit the
same trend as the complete data set. In terms of the predic-
tive utility of this technique, it is those patients with a small
increase in nucleoid scatter, correlated here to treatment
failure, which need to be identified. Within those samples
with no detectable tumour there are a wide range of forward
scatter responses, therefore while it is unlikely that normal
cell contamination will always introduce a suppressed nuc-
leoid response, on occasion this may be the case. It is clear
that for future studies a rigorous attempt at excluding non-
tumour cells must be made.
We suggest that the differences in nucleoid response be-
tween each patient group may reflect a different organisation
of DNA loops within relatively radioresistant and radiosen-
sitive cells within the tumour. This hypothesis is supported
by the data presented using squamous cell carcinoma cell
lines. Though presented here primarily as a measure of tech-
nique reproducibility, nucleoids from the radioresistant line
do scatter less light than those from radiosensitive line after
radiation. As an alternative interpretation, recent data have
shown that acute irradiation induces increased numbers of
DNA double strand breaks in relatively radiosensitive cell
lines as measured by neutral elution (Kelland et al., 1988;
Frankenberg-Schwager, 1989; McMillan et al., 1990; Sch-
wartz et al., in press). It is not thought that the double strand
breaks themselves are responsible for the differences in nuc-
leoid behaviour. Far fewer double strand breaks are pro-
duced per unit dose of irradiation than single strand breaks
and it is unlikely that their effects will directly dominate
supercoil compaction. However an association between doub-
le strand breaks and the nucleoid data cannot be ruled out.
For example, using the human squamous cell carcinoma cell
lines studied here, the radiosensitive line shows both in-
creased numbers of DNA dsb breaks after irradiation, a
decreased rate of their repair, an enhanced radiation-induced
nucleoid expansion and more fragmentation of DNA without
irradiation (Schwartz et al., 1988; Schwartz et al., 1991 and
Vaughan et al., 1991). We have previously speculated that
these observations may be linked by an alteration in chrom-
atin structure that may explain both the biophysical observa-
tions and the expression of radiosensitivity (Schwartz &
Vaughan, 1989).
In an earlier study using the V79 cell system we showed
that after irradiation, nucleoids derived from the relatively
radiosensitive monolayers were both larger and more fragile
than those from the radioresistant spheroids (Gordon et al.,
1990). In this system, neither the induction and repair of
single and double strand breaks or cell cycle stage can ex-
plain these differences in radiosensitivity (Durand & Olive,
1979). Other workers have presented similar data with nuc-
leoids extracted from a range of cell systems. For example,
using two murine lymphoma cell lines nucleoids from irrad-
iated radiosensitive LY5178S cells failed to be as effectively
compacted by ethidium bromide as radioresistant LY5178R
cells (Kapiszewska et al., 1989). Also, in a comparative study
between inherently radiosensitive human ataxia telangiectasia
(AT) fibroblasts and cells derived from normal individuals,
the AT cells also demonstrated a larger nucleoid expansion
after irradiation (Taylor et al., 1990). Finally, in studies with
lymphocyte systems, using a centrifugation technique to
quantify loop domain size, a correlation has been drawn
between radiosensitivity and a larger domain size (Filipovich
et al., 1982; Van Rensburgh et al., 1985). All the above data
suggests an association between radiosensitivity and DNA
supercoiling.
There are at least two possible mechanisms which may
explain the data presented here. A variation in DNA loop
size would allow those nucleoids with the largest loops to
give the greatest expansion when induced to relax by radia-
tion damage (Olive et al., 1986). Alternatively, the loops may
be of similar size, but the strength of their attachment to the
core protein matrix may differ (Mullenders et al., 1983). In
this case, those nucleoids with the weakest attachment may
show an enhanced relaxation after radiation exposure by the
formation of large loops in vitro, due to the parting of
multiple loops from the nuclear matrix. By definition, such
relaxation would proceed through the sites of DNA attach-
ment at the nuclear matrix, the same sites where DNA
synthesis is initiated (Nakamura et al., 1986; Pienta & Coffey,
1984) Viewed in this light, the two alternatives proposed may
be considered as matched expressions of a similar structural
alteration. For example, a weakness at the nuclear matrix-
DNA binding site may, under certain chemical treatments, be
perceived as larger DNA loops as the DNA-matrix binding
sites are separated. As we have shown with V79 cells,
nucleoids from the more radiosensitive growth form are also
the more fragile, indicating an inherent structural weakness.
Using a different technique, Cramp and colleagues studied
the association of newly synthesised DNA with its template
strand (Cramp et al., 1984). In their study, newly synthesised
DNA from radiosensitive cells was preferentially found to be
separated from its template strand when compared to radio-
resistant cell lines, suggesting a physically weaker association
within radiosensitive cells. This is the same location that is
implicated in radiosensitivity changes in this study.
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Considered together, the data reported here and in the
studies discussed above implicate the point of DNA synthesis
initiation as an important location for the modification of
cell survival after radiation exposure. It is possible that a
weakness in the insertion of DNA into the nuclear matrix
here may compromise DNA repair, especially of double
strand breaks which intuitively require a stable environment
for the correct rejoining of both strands (Schwartz et al.,
1988). In addition, DNA replication may be lethal for the
cell if there is unresolved damage at this critical location.
This raises an intriguing question as to whether or not the
configuration of DNA around the sites of DNA synthesis
may have a more wide ranging effect on the way both normal
and tumour cells process DNA damage (Pienta et al., 1989).
Thus the ability of radiation to not only kill cells, but also to
induce transformation processes and mutations, may be
modified by intrinsic chromatin architecture. These
modifications will be in addition to specific genetic factors,
such as the activity of oncogenes and the levels of various
endogenous protector substances.
In relation to the patients studied here, longer term follow
up is required to determine whether the data generated by
this technique will be useful in predicting long term disease
free survival.
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